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 Recently, a large subfamily of nucleotide-binding and oligomerization domain-containing 
proteins that have an N-terminal pyrin-like domain and C-terminal leucine-rich repeats has been 
described. In this study, we identified PYNOD, a novel member of this family that lacks the 
leucine-rich repeats. We found that human PYNOD mRNA is expressed in various tissues and at 
high levels in heart, skeletal muscle, and brain. It is also expressed in various cell lines, 
including haematopoietic cell lines. PYNOD oligomerizes and binds to ASC, an adaptor protein 
that plays a role in apoptotic and inflammatory signal transduction, and to caspase-1 and IL-1β. 
PYNOD inhibits ASC-mediated NF-κB activation and apoptosis, and caspase-1-mediated IL-1β 
maturation, and it does so in the presence and absence of constitutively active mutants of 
CARD12 and PYPAF1, which are enhancers of these processes. Thus, PYNOD is a novel 




PYNOD is a member of Apaf-1-like proteins and 
inhibits ASC-mediated NF-κB activation and 
apoptosis, and caspase-1-mediated IL-1β activation.
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